Sherwyn Schwartz, M.D.
Endocrinology, Diabetes & Metabolism Specialist
DGD research had 350 employees when sold to private equity in 2006. His name is on 1200 1572‘s and published 225 papers. He was the primary business development person and at one time was interacting with 80 companies. His interactions sometimes helped to write protocols and at other times with funding agencies like venture-capital to get money for the companies to proceed with your studies.
Dr Schwartz can function as a practitioner, researcher, key opinion leader, fundraiser and intermediary with payers.